Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services — Stella

Recruiting

Back to Schizophrenia Spectrum and Other Psychotic Disorders trials

Trial locations(6 sites)

United States

Hartford Hospital, Hartford, Connecticut

University of Georgia, Athens, Georgia

University of Chicago Medical Center, Chicago, Illinois

McLean Hospital, Belmont, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Key details

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

University of Chicago, University of Texas Southwestern Medical Center

Enrollment target

~320 participants

Started

January 2023

Primary completion

June 2027

Age range

18 Years – 40 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov